Article
No major change in vCJD agent strain after secondary transmission via blood transfusion.
PloS one - 6 Aug 2008
Bishop Matthew T, Ritchie Diane L, Will Robert G, Ironside James W, Head Mark W, Thomson Val, Bruce Moira, Manson Jean C
Abstract excerpt
BACKGROUND: The identification of transmission of variant Creutzfeldt-Jakob disease (vCJD) by blood transfusion has prompted investigation to establish whether there has been any alteration in the vCJD agent following this route of secondary transmission. Any increase in virulence or host adaptation would require a reassessment of the risk analyses relating to the possibility of a significant secondary outbreak...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
